PUBLISHER: The Business Research Company | PRODUCT CODE: 1947029
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947029
Pulmonology lasers are specialized medical devices utilized for both diagnostic and therapeutic purposes in the treatment of various respiratory conditions. These lasers emit high-energy light beams capable of precisely targeting and vaporizing abnormal or diseased tissue within the lungs. The aim of pulmonology lasers is to offer minimally invasive treatment options for respiratory diseases, thereby reducing the reliance on traditional surgery and improving patient outcomes.
The primary types of pulmonology lasers include neodymium-doped yttrium aluminum garnet (Nd-YAG) and photodynamic lasers. Nd-YAG lasers utilize a crystal that emits powerful infrared light, commonly employed in treating conditions such as bronchogenic carcinoma, malignant lesions, benign tumors, neoplasms, hemorrhage, and tracheal stenosis. End users of pulmonology lasers encompass specialty care centers, hospitals, academic institutions, and research organizations.
Tariffs are influencing the pulmonology lasers market by increasing costs of imported laser generators, optical fibers, cooling systems, and electronic control units used in nd-yag and photodynamic laser systems. Specialty care centers and hospitals in North America and Europe are most affected due to dependence on imported high-precision laser equipment, while Asia-Pacific faces pricing pressure on laser system manufacturing. These tariffs are increasing capital expenditure requirements and slowing new system installations. At the same time, they are encouraging regional manufacturing, local assembly of laser components, and innovation in cost-efficient laser platforms for respiratory care.
The pulmonology lasers market research report is one of a series of new reports from The Business Research Company that provides pulmonology lasers market statistics, including pulmonology lasers industry global market size, regional shares, competitors with a pulmonology lasers market share, detailed pulmonology lasers market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonology lasers industry. This pulmonology lasers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pulmonology lasers market size has grown strongly in recent years. It will grow from $5.52 billion in 2025 to $6.04 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing incidence of lung cancer and airway tumors, expansion of interventional pulmonology procedures, rising availability of laser-equipped hospitals, growing clinical acceptance of laser therapies, advancements in medical laser technology.
The pulmonology lasers market size is expected to see strong growth in the next few years. It will grow to $8.36 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing preference for minimally invasive respiratory treatments, growing investments in advanced interventional pulmonology tools, rising adoption of laser-based tumor management, expansion of specialty respiratory care centers, technological improvements in laser precision and control. Major trends in the forecast period include increasing adoption of minimally invasive laser therapies, rising use of nd-yag lasers in airway interventions, growing demand for precision tissue ablation, expansion of photodynamic laser applications, enhanced focus on procedure safety and accuracy.
The anticipated increase in chronic respiratory diseases is expected to drive growth in the pulmonology laser market moving forward. Chronic respiratory diseases encompass long-term conditions affecting the airways and lung structures, resulting in breathing difficulties and significantly impacting quality of life. Factors contributing to the rise in these diseases include air pollution, smoking, an aging population, rapid urbanization, and climate changes. Pulmonology lasers play a crucial role in the diagnosis and treatment of chronic respiratory diseases through procedures such as diagnostic bronchoscopy and therapeutic interventions such as addressing airway obstructions or tumors. For example, as of June 2024, the Australian Institute of Health and Welfare reported that approximately 2.8 million Australians, accounting for 11% of the population, were estimated to have asthma, a common chronic respiratory condition. Additionally, about 638,000 individuals, or 2.5% of the population, were living with chronic obstructive pulmonary disease (COPD), a condition that contributed significantly to mortality rates in Australia, constituting 4.0% of deaths that year. Thus, the increasing prevalence of chronic respiratory diseases underscores their role in propelling growth within the pulmonology laser market.
The increasing adoption of minimally invasive surgeries is expected to propel the growth of the pulmonology lasers market going forward. Minimally invasive surgeries involve medical procedures that access the body through small incisions or natural openings to treat or diagnose conditions. The rise in minimally invasive surgeries is driven by benefits such as reduced recovery time and hospital stays, lower risk of complications, less pain and scarring, and greater procedural precision through advanced technologies. This trend supports the pulmonology lasers market by reducing patient trauma, enhancing procedural accuracy, and increasing demand for advanced laser technologies in bronchoscopic and thoracoscopic procedures. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures grew by 7% in 2023, outpacing overall surgical procedure growth by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% increase from 2022. Therefore, the rising adoption of minimally invasive surgeries is driving the growth of the pulmonology lasers market.
The growing geriatric population is expected to propel the growth of the pulmonology lasers market going forward. The geriatric population includes older adults, typically aged 65 and above, who often need specialized healthcare due to age-related physiological changes. This population is expanding primarily because of increased life expectancy and declining birth rates, which lower the proportion of younger individuals. Pulmonology lasers benefit the geriatric population by enabling precise, minimally invasive treatments that improve respiratory function, reduce procedural risks, and enhance overall quality of life for older patients. For instance, in July 2024, according to the UK Parliament's House of Commons Library, a UK-based government administration, there were 12.7 million people aged 65 or older in the UK in 2022, representing 19% of the total population. This number is projected to reach 22.1 million by 2072, accounting for 27% of the population. Therefore, the growing geriatric population is driving the growth of the pulmonology lasers market.
Major companies operating in the pulmonology lasers market are Coherent Corp., IPG Photonics Corporation, Han's Laser Technology Industry Group, Lumenis Ltd, Biolitec AG, Ellex Medical Pty Ltd, Fotona LLC, Spectra-Physics Inc., Lumibird SA, EKSPLA Co, Optotek Medical, Optogama UAB, Beijing Hoplaser Lead-Edge Laser Techno. Ltd, Amada Miyachi, Richard Wolf GmbH, Karl Storz SE And Co. KG, Olympus Medical Systems Corp., Boston Scientific Corporation, Dornier MedTech, Asclepion Laser Technologies GmbH
North America was the largest region in the pulmonology lasers market in 2025. The regions covered in the pulmonology lasers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pulmonology lasers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The pulmonology lasers market consists of sales of laser systems, laser fibers and probes, protective eyewear, smoke evacuators, and disposable components. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pulmonology Lasers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pulmonology lasers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pulmonology lasers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pulmonology lasers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.